QIAGEN N.V. — États financiers trimestriels (NYSE:QGEN)

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes

Trimestriel Annuel

Market Capitalization 7.94 B
Employee 5 654
Founded 1984
CEO Thierry Bernard
Website www.qiagen.com
Headquarter Netherlands
FIGI UNKNOWN
Industry Diagnostic et Recherche

Chiffre d'affaires total

Résultat net

Dette totale

Flux de trésorerie disponible

Trésorerie et équivalents de trésorerie

Dividende par action

0.25

Rendement du dividende (%)

0.56

Qiagen N.V. Common Shares

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.